Clinical Trial Update: Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the safety and efficacy of Ingenol Mebutate Gel 0.015% and 0.05% for actinic keratosis has completed, with results posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel 0.05% (ingenol mebutate)
• Ingenol Mebutate Gel, 0.015% (ingenol mebutate)

Snippet

Sponsor: Korea University | Conditions: Actinic Keratosis | Phase 4 | Status: COMPLETED | Results posted: 2018-04-18